Supplementary tables: Efficacy of tucatinib for HER2-positive metastatic breast cancer after HER2-targeted therapy: a network meta-analysis.docx
收藏数据链接：
官方服务：
资源简介：
Supplementary Table 1. Search terms used in Embase (A) Initial systematic review search, January 22, 2020; (B, C) November 23, 2020 Supplementary Table 2. Systematic literature review eligibility criteria used to identify relevant randomized trials Supplementary Table 3. Risk of bias assessment for studies included in the NMA
提供机构：
Taylor & Francis创建时间：
2021-08-31
